Dr. Roach: Dr. The 66 -year -old husband was diagnosed with heart failure due to the recent preserved emission rate. He is 5 feet tall and 7 inches and weighs 270 pounds. He treats his body fluid with three mids of 100mg every day. He also has a light absorption absorption.
He wants to test one of the GLP-1 drugs to reduce his weight, but he is concerned about pancreatitis because of alcohol consumption. (He drinks 6-7 whiskey a day.) My first doctor said that when I drink it while taking this medicine, some people are very sick when I drink.
In this evening news broadcast, there was a story about those who succeeded in fighting alcoholism during the use of this medicine, and we heard that they helped sleep apnea. In your opinion, is it beneficial and safe to try?
-BV
Dear BV: Heart failure maintains the low pressure of the heart so that the blood of the lungs is discharged properly while the heart’s ability to provide all the blood that the body needs is reduced. Heart failure of the preserved discharge rate (HFPEF) means that the heart can be squeezed properly, but the main problem is that it is relaxed at low pressure. Due to the pressure pressure, a fluid backup occurs, resulting in volume overload (also called a fluid retention).
Puro three and other diuretics can be helpful for symptoms, but drugs that have a significant impact on the management of HFPEF are the first drugs used in diabetes, SGLT2 inhibitors such as Empagliflozin, and GLP-1 agents such as PEMAGLUTIDE (person with HFPEF and obesity). The drug has shown that people help to lose weight and reduce heart failure hospitalization.
Pancreatitis has been reported to those taking GLP-1 drugs. However, there is a low risk per 1,000 people taking drugs for one year. It is not yet clear that the risk of pancreatitis is higher in these drugs than other drugs. Nevertheless, I hesitate to use this for a person with a history of pancreatitis. If pancreatitis occurs during treatment, the GLP-1 drug will not stop and start again.
GLP-1 drugs have an initial and implicit data that reduces alcohol cravings. Mass of people with alcohol disorders have reduced the risk of hospitalization for alcohol or other materials for those who take three hemp glue or liragluthides.
Other studies have shown that alcohol use has decreased while treating three of the three retail or Tirbepet. These results have not been identified as a random clinical trial, but experts are optimistic. Alcohol -related heart failure is generally caused by a decrease in unbutty release rate, but the amount of alcohol he is taking is toxic to the heart.
Given the husband’s severe obesity (42.3), the advantage of the GLP-1 formulation for weight, heart failure and alcohol use greatly surpasses the potential damage of pancreatitis. Finally, people with sleep apnea and obesity have strong data showing that GLP-1 zero treatment can reduce sleep apnea. Charles Dickens knew this in 1836 and wrote a very clear explanation in his first novel, “Pickwick Club’s post -paper.”The reader can send a question by email to Toyourgoodhealth@med.cornell.edu.
